---------- Forwarded message ----------
From: PlusNews <[email protected]>
Date: Wed, Jul 25, 2012 at 12:16 PM
Subject: HIV/AIDS: New ways to fund the fight
To: Elisabeth Janaina <[email protected]>


HIV/AIDS: New ways to fund the fight

WASHINGTON DC, 25 July 2012 (PLUSNEWS) - While global HIV funding has
stayed flat in recent years, poorer countries have quietly been
putting more of their own money into financing the HIV response.
"Something very interesting has been happening" in Africa, Bernhard
Schwartländer, director of strategy at UNAIDS told a plenary session
at the 19th International AIDS Conference in Washington DC.

Treatment numbers are rising despite stagnant funding. "A lot of very
clever and dedicated people are working very hard in making sure that
services are delivered more efficiently, and. more people receive HIV
services with the same amount of money."

Domestic spending on HIV/AIDS in several African countries, including
Kenya, Namibia, Sierra Leone and Uganda, rose by more than 100 percent
between 2006 and 2011. For the first time ever, domestic resources
exceed international AIDS spending as national governments take on the
challenge of redistributing resources, UNAIDS noted.

But the reality is that national AIDS programmes have expanded beyond
the capacity of governments to fully support them. If Malawi, for
instance, took on the financing of its antiretroviral (ARV) programme
- currently funded entirely by the Global Fund to fight AIDS,
Tuberculosis (TB) and Malaria - this would consume two-thirds of its
overall health budget, said Sharonann Lynch, policy advisor at
international health charity Médecins Sans Frontières (MSF).

Poorer governments are still largely dependent on global resources.
"The lives of 80 percent of the people who receive AIDS treatment in
Africa depend every day, every morning, on whether or not the donor
writes another cheque. That is unacceptable - such dependency simply
must end," said Schwartländer.

New sources of income

As an alternative to donor support, innovative financing mechanisms to
bridge the funding gap are gaining increasing support from
governments. Zimbabwe's AIDS levy - a 3 percent income tax - generated
more than US$26 million in 2011, UNAIDS reported recently. However,
Albert Manenji, finance director of Zimbabwe's National AIDS Council,
told IRIN/PlusNews that only 30 percent of Zimbabweans were in the
formal sector and contributed to the levy, so they are looking at
broadening the revenue base to include small businesses and the
informal sector.

Rwanda and Uganda have begun to impose a levy on the use of mobile
phones to fund health programmes, and Botswana, Gabon and Malawi,
among others, are investigating such a levy specifically for AIDS
financing.

Imposing a "sin tax" on alcohol and tobacco to pay for universal
access to ARVs could be one of the most ambitious taxes to be
implemented.

Modelling [ http://pag.aids2012.org/Abstracts.aspx?AID=2816 ] by
Liverpool University researchers based on the 20 countries with the
highest HIV burden suggests that 10 of these countries, including
South Africa, Botswana and Malawi, could fully fund universal access
over the coming years if governments put a small "global health
charge" on alcohol and cigarettes.

Andrew Hill, a research fellow at Liverpool University, said the
proposed tax would also generate "substantial additional funds to
treat malaria, tuberculosis and other diseases". Raising taxes could
also deter the use of cigarettes and alcohol, lowering the burden of
non-communicable diseases linked to smoking and drinking.

The idea of a "sin tax" has long been popular in developed countries,
and now the "fat tax", a levy on sugary drinks and other foodstuffs
associated with obesity, is also growing in momentum. But Hill
admitted that enforcing these taxes in poorer countries would be
difficult.

Schwartländer also suggested that the recent fines imposed on large
pharmaceutical firms could be set aside for health assistance, "rather
than disappear in the general coffers of those countries".

In July 2012, British drugmaker GlaxoSmithKline pleaded guilty to
criminal charges and agreed to pay $3 billion in fines for promoting
its best-selling antidepressants for unapproved uses, and failing to
report safety data about a top diabetes drug.

Schwartländer pointed out that "three billion dollars could easily pay
for a year of drugs for all those on treatment today".

kn/he[END]

This report online: http://www.plusnews.org/report.aspx?reportID=95946



Follow us on Twitter! http://twitter.com/plusnews

© IRIN. All rights reserved. HIV/AIDS news and analysis:
http://www.plusnews.org/

[This item comes to you from PlusNews, part of IRIN, the humanitarian
news and analysis service of the UN Office for the Coordination of
Humanitarian Affairs. The opinions expressed do not necessarily
reflect those of the United Nations or its Member States. Reposting or
reproduction, with attribution, for non-commercial purposes is
permitted. Terms and conditions: http://www.irinnews.org/copyright

Principal IRIN/PlusNews donors: UAE, Canada, Germany, Ireland,
Netherlands, Norway, Sweden, Switzerland, UK and the IHC. More
information: http://www.irinnews.org/donors

This mail is from an automatic address. Contact PlusNews at:
[email protected]. Revise/stop your subscription:
http://bit.ly/9nCoUP ]

Subscribed email: [email protected]

-- 
You received this message because you are subscribed to the Google Groups 
"South Sudan Info - The Kob" group.
To post to this group, send email to [email protected].
To unsubscribe from this group, send email to 
[email protected].
For more options, visit https://groups.google.com/groups/opt_out.


Reply via email to